LONDON, UK / ACCESSWIRE / May 21, 2019 / Rapid Nutrition PLC (OTCQB: RPNRF) ("Company"), a natural healthcare company focused…
ENGLEWOOD, CO / ACCESSWIRE / May 21, 2019 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on…
WESTLAKE VILLAGE, CA / ACCESSWIRE / May 21, 2019 / Arcutis, Inc., a privately held immuno-dermatology drug development company addressing…
HAMBURG, GERMANY / ACCESSWIRE / May 20, 2019 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809, WKN 566480)…
FT. MYERS, FL / ACCESSWIRE / May 20, 2019 / NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic…
EVOTEC'S OFFERING OF INTEGRATED SOLUTIONS EXTENDED TO BIOLOGICS ADDITION OF LONGSTANDING BIOLOGICS EXPERTISE BASED ON KEY TALENTS, INNOVATIVE ML (MACHINE…
SAN CLEMENTE, CA / ACCESSWIRE / May 20, 2019 / ReShape Lifesciences Inc. (OTCQB: RSLS), a developer of minimally invasive…
KINDERHOOK, NY / ACCESSWIRE / May 20, 2019 / American Bio Medica Corporation (OTC PINK: ABMC) today announced financial results…
Biom'up to Present at the RBC Capital Markets Global Healthcare Conference on Tuesday May 21, 2019 in New York City…
DURHAM, NC / ACCESSWIRE / May 20, 2019 / Heat Biologics, Inc. (NASDAQ: HTBX), a biopharmaceutical company developing therapies designed…
SAN CLEMENTE, CA / ACCESSWIRE / May 20, 2019 / ReShape Lifesciences Inc. (OTCQB: RSLS), a developer of minimally invasive…
TORONTO, ON / ACESSWIRE / May 20, 2019 / Theralase® Technologies Inc. ("Theralase" or the "Company") (TSXV: TLT) (OTCQB: TLTFF),…
DUBLIN, IRELAND / ACCESSWIRE / May 20, 2019 / GC Aesthetics (GCA) announced today that data from a European clinical…
Biom'up provides 2019 guidance for HEMOBLAST TM Bellows global sales Biom'up provides full-year 2019 guidance for global sales of HEMOBLAST…
CALGARY, AB / ACCESSWIRE / May 17, 2019 / Calgary, AB: Prevent Health Care International Corp. (the "Corporation") today announced…
MOUNT PROSPECT, IL / ACCESSWIRE / May 16, 2019 / Smile Solutions Dental Center is proud to announce that it…
MONTREAL, QC / ACCESSWIRE / May 16, 2019 / Sunshine Biopharma, Inc. (OTC PINK: SBFM) today announced that its recently…
ARQ-151 Potential "Best in Class" Topical PDE4 inhibitor Phase 1 Study in Atopic Dermatitis Completed Phase 2 Study Initiation Anticipated…
VANCOUVER, BC / ACCESSWIRE / May 15, 2019 / EastWest Bioscience (the "Company"or "EastWest") (TSX.V: EAST) announces that on May…
Company Launches National Marketing Campaign to Promote Telehealth Business Model, Processes First Patient-Directed Orders, In Discussions With International Distributor for…